Canbay, A.; Götze, O.; Kucukoglu, O.; Weinert, S.; Croner, R.S.; Baars, T.; Özçürümez, M.K.; Gieseler, R.K.
l-Ornithine-l-Aspartate (LOLA) Normalizes Metabolic Parameters in Models of Steatosis, Insulin Resistance and Metabolic Syndrome. Pharmaceutics 2024, 16, 506.
https://doi.org/10.3390/pharmaceutics16040506
AMA Style
Canbay A, Götze O, Kucukoglu O, Weinert S, Croner RS, Baars T, Özçürümez MK, Gieseler RK.
l-Ornithine-l-Aspartate (LOLA) Normalizes Metabolic Parameters in Models of Steatosis, Insulin Resistance and Metabolic Syndrome. Pharmaceutics. 2024; 16(4):506.
https://doi.org/10.3390/pharmaceutics16040506
Chicago/Turabian Style
Canbay, Ali, Oliver Götze, Ozlem Kucukoglu, Sönke Weinert, Roland S. Croner, Theodor Baars, Mustafa K. Özçürümez, and Robert K. Gieseler.
2024. "l-Ornithine-l-Aspartate (LOLA) Normalizes Metabolic Parameters in Models of Steatosis, Insulin Resistance and Metabolic Syndrome" Pharmaceutics 16, no. 4: 506.
https://doi.org/10.3390/pharmaceutics16040506
APA Style
Canbay, A., Götze, O., Kucukoglu, O., Weinert, S., Croner, R. S., Baars, T., Özçürümez, M. K., & Gieseler, R. K.
(2024). l-Ornithine-l-Aspartate (LOLA) Normalizes Metabolic Parameters in Models of Steatosis, Insulin Resistance and Metabolic Syndrome. Pharmaceutics, 16(4), 506.
https://doi.org/10.3390/pharmaceutics16040506